Ivermectin Evidence with Dr Tess Lawrie
Thank you very much Dr. Lawrie.
Ivermectin interview, Dr. Tess Lawrie
Ivermectin reduces the risk of death from COVID-19 -a rapid review and meta-analysis in support of the recommendation of the Front Line COVID-19 Critical Care Alliance.
https://www.researchgate.net/publication/348297284_Ivermectin_reduces_the_risk_of_death_from_COVID-19_-a_rapid_review_and_meta-analysis_in_support_of_the_recommendation_of_the_Front_Line_COVID-19_Critical_Care_Alliance_Latest_version_v12_-_6_Jan_2021
Kory P, Meduri GU, Iglesias J, et al. Review of the emerging evidence demonstrating the efficacy of ivermectin in the prophylaxis and treatment of COVID-19. 18 Dec 2020.
https://covid19criticalcare.com/wp-content/uploads/2020/11/FLCCC-Ivermectin-in-the-prophylaxis-and-treatment-of-COVID-19.pdf
World Health Organization. 21st Model List of Essential Medicines. Geneva, Switzerland. 2019.
https://www.who.int/publications/i/item/WHOMVPEMPIAU2019.06
Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 6.0 Cochrane, 2019.
www.training.cochrane.org/handbook.
The GRADE Working Group. GRADE [website] 2020
www.gradeworkinggroup.org.
Alam MT, Murshed R, Gomes PF, Masud ZM, Saber S, Chaklader MA, Khanam F, Hossain M, Momen ABIM, Yasmin N, Alam RF, Sultana A, Robin RC. Ivermectin as Pre-exposure Prophylaxis for COVID-19 among Healthcare Providers in a Selected Tertiary Hospital in Dhaka – An Observational Study
https://ejmed.org/index.php/ejmed/article/view/599
Elgazzar A, Eltaweel A, Youssef SA, Hany B, Hafez M and Moussa H. Efficacy and Safety of ivermectin for Treatment and prophylaxis of COVID-19 Pandemic. Res. Square [Internet] 28Dec.2020
https://www.researchsquare.com/article/rs-100956/v3
Chowdhury, ATMM, Shahbaz, M, Karim, MR, Islam, J, Guo, D, and He, SA Randomized Trial of Ivermectin-Doxycycline and Hydroxychloroquine-Azithromycin therapy on COVID19 patients.
https://www.researchsquare.com/article/rs-38896/v1
Podder CS, Chowdhury N, Mohim IS and Haque W. (2020). Outcome of ivermectin treated mild to moderate COVID-19 cases: a single-centre, open-label, randomised controlled study. IMC Journal of Medical Science.
Niaee MS, Gheibi N, Namdar P, Allami A, Zolghadr L, Javadi A, et al. Ivermectin as an adjunct treatment for hospitalized adult COVID-19 patients: A randomized multi-centre clinical trial. Res. Square [Internet] 24Nov.2020
https://www.researchsquare.com/article/rs-109670/v1
Hashim HA, Maulood MF, Rasheed AM, Fatak DF, Kabah KK, Abdulami AS, et al. Controlled randomized clinical trial on using Ivermectin with Doxycycline for treating COVID-19 patients in Baghdad, Iraq. medRxiv [Internet] 2020.10.26.20219345
https://doi.org/10.1101/2020.10.26.20219345
Ahmed S, Karim MM, Ross AG, Hossain MS, Clemens JD, Sumiya MK, et al. A five day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness. Int. J. Infect. Disease [Internet] 2Dec.2020.
https://www.ijidonline.com/article/S1201-9712(20)32506-6/fulltext
Chachar AZK, Khan KA, Asif M, Tanveer K, Khaqan A and Basri R. Effectiveness of Ivermectin in SARS-CoV-2/COVID-19 Patients, Int. J. Sciences [Internet] Nov.2020:31-V1.2 6th January 2021 20 35
https://www.ijsciences.com/pub/article/2378
Cepelowicz Rajter J, Sherman MS, Fatteh N, Vogel F, Sacks J and Rajter JJ. Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019. J. Chest [Internet] 27Oct.2020.
https://journal.chestnet.org/action/showPdf?pii=S0012-3692%2820%2934898-4
Khan SI, Khan SI, Debnath CR, Nath PN, Al Mahtab M, Nabeka H, et al. [Ivermectin Treatment May Improve the Prognosis of Patients With COVID-19.] Archivos de Bronconeumología, 2020. Volume 56, Issue 12, Pages 828-830,ISSN 0300- 2896.Spain.
https://doi.org/10.1016/j.arbres.2020.08.007.
Gorial FI, Mashhadani S, Sayaly HM, Dakhil BD, AlMashhadani MM, Aljabory AM, et al. Effectiveness of Ivermectin as add-on Therapy in COVID-19 Management (Pilot Trial).MedRxiv. 2020.07.07.20145979;
https://doi.org/10.1101/2020.07.07.20145979
Spoorthi V, Sasank S. Utility of ivermectin and doxycycline combination for the treatment of SARS-CoV-2. International Archives of Integrated Medicine.
https://www.iaimjournal.com/volume-7-issue-10- october-2020/
“I can’t keep doing this.” Doctor pleads for review of data during COVID-19 Senate hearing. 8 December 2020.
https://www.youtube.com/watch?v=Tq8SXOBy-4w
Видео Ivermectin Evidence with Dr Tess Lawrie канала Dr. John Campbell
Ivermectin interview, Dr. Tess Lawrie
Ivermectin reduces the risk of death from COVID-19 -a rapid review and meta-analysis in support of the recommendation of the Front Line COVID-19 Critical Care Alliance.
https://www.researchgate.net/publication/348297284_Ivermectin_reduces_the_risk_of_death_from_COVID-19_-a_rapid_review_and_meta-analysis_in_support_of_the_recommendation_of_the_Front_Line_COVID-19_Critical_Care_Alliance_Latest_version_v12_-_6_Jan_2021
Kory P, Meduri GU, Iglesias J, et al. Review of the emerging evidence demonstrating the efficacy of ivermectin in the prophylaxis and treatment of COVID-19. 18 Dec 2020.
https://covid19criticalcare.com/wp-content/uploads/2020/11/FLCCC-Ivermectin-in-the-prophylaxis-and-treatment-of-COVID-19.pdf
World Health Organization. 21st Model List of Essential Medicines. Geneva, Switzerland. 2019.
https://www.who.int/publications/i/item/WHOMVPEMPIAU2019.06
Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 6.0 Cochrane, 2019.
www.training.cochrane.org/handbook.
The GRADE Working Group. GRADE [website] 2020
www.gradeworkinggroup.org.
Alam MT, Murshed R, Gomes PF, Masud ZM, Saber S, Chaklader MA, Khanam F, Hossain M, Momen ABIM, Yasmin N, Alam RF, Sultana A, Robin RC. Ivermectin as Pre-exposure Prophylaxis for COVID-19 among Healthcare Providers in a Selected Tertiary Hospital in Dhaka – An Observational Study
https://ejmed.org/index.php/ejmed/article/view/599
Elgazzar A, Eltaweel A, Youssef SA, Hany B, Hafez M and Moussa H. Efficacy and Safety of ivermectin for Treatment and prophylaxis of COVID-19 Pandemic. Res. Square [Internet] 28Dec.2020
https://www.researchsquare.com/article/rs-100956/v3
Chowdhury, ATMM, Shahbaz, M, Karim, MR, Islam, J, Guo, D, and He, SA Randomized Trial of Ivermectin-Doxycycline and Hydroxychloroquine-Azithromycin therapy on COVID19 patients.
https://www.researchsquare.com/article/rs-38896/v1
Podder CS, Chowdhury N, Mohim IS and Haque W. (2020). Outcome of ivermectin treated mild to moderate COVID-19 cases: a single-centre, open-label, randomised controlled study. IMC Journal of Medical Science.
Niaee MS, Gheibi N, Namdar P, Allami A, Zolghadr L, Javadi A, et al. Ivermectin as an adjunct treatment for hospitalized adult COVID-19 patients: A randomized multi-centre clinical trial. Res. Square [Internet] 24Nov.2020
https://www.researchsquare.com/article/rs-109670/v1
Hashim HA, Maulood MF, Rasheed AM, Fatak DF, Kabah KK, Abdulami AS, et al. Controlled randomized clinical trial on using Ivermectin with Doxycycline for treating COVID-19 patients in Baghdad, Iraq. medRxiv [Internet] 2020.10.26.20219345
https://doi.org/10.1101/2020.10.26.20219345
Ahmed S, Karim MM, Ross AG, Hossain MS, Clemens JD, Sumiya MK, et al. A five day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness. Int. J. Infect. Disease [Internet] 2Dec.2020.
https://www.ijidonline.com/article/S1201-9712(20)32506-6/fulltext
Chachar AZK, Khan KA, Asif M, Tanveer K, Khaqan A and Basri R. Effectiveness of Ivermectin in SARS-CoV-2/COVID-19 Patients, Int. J. Sciences [Internet] Nov.2020:31-V1.2 6th January 2021 20 35
https://www.ijsciences.com/pub/article/2378
Cepelowicz Rajter J, Sherman MS, Fatteh N, Vogel F, Sacks J and Rajter JJ. Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019. J. Chest [Internet] 27Oct.2020.
https://journal.chestnet.org/action/showPdf?pii=S0012-3692%2820%2934898-4
Khan SI, Khan SI, Debnath CR, Nath PN, Al Mahtab M, Nabeka H, et al. [Ivermectin Treatment May Improve the Prognosis of Patients With COVID-19.] Archivos de Bronconeumología, 2020. Volume 56, Issue 12, Pages 828-830,ISSN 0300- 2896.Spain.
https://doi.org/10.1016/j.arbres.2020.08.007.
Gorial FI, Mashhadani S, Sayaly HM, Dakhil BD, AlMashhadani MM, Aljabory AM, et al. Effectiveness of Ivermectin as add-on Therapy in COVID-19 Management (Pilot Trial).MedRxiv. 2020.07.07.20145979;
https://doi.org/10.1101/2020.07.07.20145979
Spoorthi V, Sasank S. Utility of ivermectin and doxycycline combination for the treatment of SARS-CoV-2. International Archives of Integrated Medicine.
https://www.iaimjournal.com/volume-7-issue-10- october-2020/
“I can’t keep doing this.” Doctor pleads for review of data during COVID-19 Senate hearing. 8 December 2020.
https://www.youtube.com/watch?v=Tq8SXOBy-4w
Видео Ivermectin Evidence with Dr Tess Lawrie канала Dr. John Campbell
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Dr. Paul Marik Discusses Ivermectin and Vitamin DDr Lawrie, Ivermectin video, Short PrecisIvermectin discussion with Dr Tess LawrieCOVID-19 Management With Dr. Paul Marik - Author Of MATH+ ProtocolGlobal updateVitamins D and K2Ivermectin and COVID: what's going on? (Dr Carlos Chaccour, ISGlobal)CoViD SymptomsICON Study: Use of Ivermectin in Hospitalized Patients With COVID-19 | January 2021 Journal Club#KalingangKatribu with Cory Quirino featuring Dr. Allan LandritoCanada UpdateCoronavirus VariantsDeaths, Anaphylaxis, And Other Vaccine Adverse Effects (March 16th 2021 - USA)Medical exemptions and IvermectinVaccination in immune compromiseShould I Prescribe Ivermectin for COVID 19? | Ivermectin Update 2021LIVE: Anti-Vaccine Doctor Testifies at Senate Homeland Security Hearing on Covid-19 TreatmentsVaccine side effectsUK cases level, India increasesDetailed vaccine safety update